Longevity
3 articles

Biotech & Health
Longevity Science's Ethical Divide: Will Only the Rich Live Forever?
Experts warn that extended lifespans could lead to "longevity without security," forcing additional decades of work and financial strain on those without corresponding societal reforms, according to t
Juliana Campos·September 12, 2026

Biotech & Health
AI Accelerates Whole Body Rejuvenation Drug Discovery for Healthspan
David Sinclair plans to launch human tests of an oral 'reprogramming' drug as part of a $101 million XPrize competition, according to MIT Technology Review .
Lena Petrova·June 10, 2026

Biotech & Health
David Sinclair's Company Gets FDA Nod for Rejuvenation Trial
Life Biosciences, co-founded by prominent longevity researcher David Sinclair, has received FDA approval to begin the first human trial for a 'rejuvenation treatment' called ER-100.
Lena Petrova·June 9, 2026
